12:00 AM
Nov 05, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Levodopa/carbidopa/entacapone: Phase II data

A European Phase II trial in >100 advanced PD patients showed that ODM-101 was more effective than Stalevo levodopa/carbidopa/entacapone in reducing time periods during the day when patients do not have...

Read the full 142 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >